Counterfeits of drugs like Ozempic cost pharma companies billions of dollars annually. We look at the tech solutions that can help tackle the problem

CB Insights July 25, 2024
Jacqueline Tubbs

As concerns mount around the rise of counterfeit drugs, supply chain technologies such as IoT asset tracking, blockchain ledgers, and product & packaging authentication can provide pharma companies with more visibility and supply chain security.

Interest in Ozempic — a GLP-1 receptor agonist developed to treat Type 2 diabetes — has skyrocketed due to its off-label use for rapid weight loss in recent years.

The impact on the pharma industry has been substantial, with Ozempic’s producer, Novo Nordisk, seeing a 36% rise in sales in 2023 driven by the accelerated adoption of its GLP-1 products. D2C pharmacies like Hims are also entering the space, offering their own GLP-1 drugs at a fraction of the cost to patients.

The...

Today's Sponsors

Today's Sponsor